Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 4 studies | 21% ± 6% | |
erythrocyte | 3 studies | 24% ± 5% |
Insufficient scRNA-seq data for expression of TSPAN17 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1473.04 | 180 / 180 | 100% | 32.31 | 430 / 430 |
pancreas | 100% | 1838.40 | 328 / 328 | 100% | 37.43 | 178 / 178 |
uterus | 100% | 1755.01 | 170 / 170 | 100% | 37.81 | 459 / 459 |
lung | 100% | 2299.16 | 578 / 578 | 100% | 36.16 | 1154 / 1155 |
stomach | 100% | 1960.11 | 358 / 359 | 100% | 26.24 | 286 / 286 |
kidney | 100% | 2748.12 | 89 / 89 | 100% | 29.14 | 898 / 901 |
esophagus | 100% | 1946.27 | 1445 / 1445 | 99% | 24.20 | 182 / 183 |
bladder | 100% | 2001.71 | 21 / 21 | 99% | 35.64 | 501 / 504 |
prostate | 100% | 2477.41 | 245 / 245 | 99% | 28.12 | 499 / 502 |
skin | 100% | 2318.59 | 1809 / 1809 | 99% | 36.70 | 469 / 472 |
thymus | 100% | 2109.60 | 653 / 653 | 99% | 23.17 | 601 / 605 |
breast | 100% | 1690.39 | 459 / 459 | 99% | 34.87 | 1110 / 1118 |
intestine | 100% | 1956.23 | 966 / 966 | 99% | 33.00 | 523 / 527 |
brain | 99% | 1854.43 | 2621 / 2642 | 100% | 25.61 | 705 / 705 |
liver | 100% | 1313.06 | 226 / 226 | 99% | 23.51 | 401 / 406 |
adrenal gland | 100% | 4723.62 | 258 / 258 | 97% | 41.54 | 223 / 230 |
adipose | 100% | 1633.79 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 34.86 | 29 / 29 |
muscle | 100% | 2411.59 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2824.42 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 50.31 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 9.07 | 1 / 1 |
blood vessel | 100% | 1228.28 | 1331 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 1706.94 | 856 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 1254.88 | 919 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 99% | 25.25 | 79 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0072594 | Biological process | establishment of protein localization to organelle |
GO_0051043 | Biological process | regulation of membrane protein ectodomain proteolysis |
GO_0005886 | Cellular component | plasma membrane |
GO_0019899 | Molecular function | enzyme binding |
Gene name | TSPAN17 |
Protein name | Tetraspanin 17 Tetraspanin-17 (Tspan-17) (F-box only protein 23) (Tetraspan protein SB134) (Transmembrane 4 superfamily member 17) Tetraspanin |
Synonyms | TM4SF17 FBXO23 |
Description | FUNCTION: Part of TspanC8 subgroup, composed of 6 members that interact with the transmembrane metalloprotease ADAM10. This interaction is required for ADAM10 exit from the endoplasmic reticulum and for enzymatic maturation and trafficking to the cell surface as well as substrate specificity. Different TspanC8/ADAM10 complexes have distinct substrates . Seems to regulate VE-cadherin expression in endothelial cells probably through interaction with ADAM10, promoting leukocyte transmigration . . |
Accessions | D6RI03 ENST00000310032.12 J3KNG2 D6RBW9 ENST00000507471.1 ENST00000504168.5 Q96FV3 ENST00000503045.5 D6RDX8 ENST00000508164.6 [Q96FV3-4] ENST00000515708.5 [Q96FV3-3] ENST00000503030.1 ENST00000298564.14 [Q96FV3-2] H0Y9A5 |